
Your Feed
Filter by
See content from
Playlist: IMS 2025
MGIP: The Earliest Warning Sign of Myeloma Evolution | Sungjae Kim, PhD | #IMS2025
Video details & playlist
Playlist: IMS 2025
CELMoDs: Boosting T-Cell Therapies with Iberdomide & Mezigdomide | Joshua Richter, MD| #IMS2025
Video details & playlist
Playlist: IMS 2025
Ferritin & ALC Predict PFS in Myeloma Bispecific Antibody Therapy | Tarek Mouhieddine, MD #IMS25
Video details & playlist
Playlist: IMS 2025
Blood Test Reveals Myeloma Genetics Using Cell-Free DNA | Dory Abelman, PhdD(c) #IMS25
Video details & playlist
Playlist: IMS 2025
How MRD Status Is Being Used to Guide Myeloma Treatment Decisions | Ben Derman MD #IMS25
Video details & playlist
Playlist: IMS 2025
Lymphocyte Count Used to Predict Delayed Neurotoxicity in Myeloma CAR-T | Hitomi Hosoya MD #ims25
Video details & playlist
Playlist: IMS 2025
Shared Decision-Making Matters When Choosing Myeloma Treatment | Martine Elias,Myeloma Canada #IMS25
Video details & playlist
Playlist: IMS 2025
MRD Relapse vs Biochemical Relapse -Restarting Myeloma Therapy | Fredrik Schjesvold, MD, PhD #IMS25
Video details & playlist




